| Literature DB >> 32917136 |
Shuangyang Dai1, Xiaobin Zhou2, Hong Xu3, Beibei Li1, Jingao Zhang1.
Abstract
BACKGROUNDS: Master of public health (MPH) plays an important role in Chinese medical education, and the dissertations is an important part of MPH education. In MPH dissertations, most are observational studies. Compared with randomized controlled trial (RCT), observational studies are more prone to information bias. So, the reporting of the observational studies should be transparent and standard. But, no research on evaluating the reporting quality of the MPH dissertation has been found.Entities:
Keywords: Dissertation; Evaluating; Master of public health; Observational studies; Reporting quality
Mesh:
Year: 2020 PMID: 32917136 PMCID: PMC7488525 DOI: 10.1186/s12874-020-01116-6
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Flow diagram of the literature
Adherence to the STROBE Reporting Criteria
| Item | Recommendation | Fully Reported (%) | Partly Reported (%) | |
|---|---|---|---|---|
| 1 | (a) Indicat the study’s design with a commonly used term in the title or the abstract | 164 (99.39) | 0 (0) | |
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found | 163 (98.79) | 0 (0) | ||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 158 (95.75) | 7 (4.25) |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 165 (100) | 0 (0) |
| Study design | 4 | Present key elements of study design early in the paper | 165 (100) | 0 (0) |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 129 (78.18) | 28 (16.97) |
| Participants | 6 | (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up Case-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants | 89 (53.94) | 31(23. 64) |
(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposed Case-control study—For matched studies, give matching criteria and the number of controls per case | 41(73.21) | 0 (0) | ||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 52 (31.52) | 98 (59.39) |
| Data sources | 8 | For each variable of interest, give sources of data and details of methods of assessment zhg (measurement). Describe comparability of assessment methods if there is more than one group | 127 (76.97) | 17 (10.30) |
| Bias | 9 | Describe any efforts to address potential sources of bias | 135 (81.82) | 0 (0) |
| Study size | 10 | Explain how the study size was arrived at | 70 (42.42) | 0 (0) |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 21 (12.73) | 33 (20.00) |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | 141 (85.45) | 16 (9.70) |
| (b) Describe any methods used to examine subgroups and interactions | 11(6.67) | 0 (0) | ||
| (c) Explain how missing data were addressed | 11(6.67) | 0 (0) | ||
(d) Cohort study—If applicable, explain how loss to follow-up was addressed Case-control study—If applicable, explain how matching of cases and controls was addressed Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy | 36 (21.82) | 0 (0) | ||
| (e) Describe any sensitivity analyses | 6 (3. 63) | 0 (0) | ||
| Participants | 13 | (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 49 (29.70) | 116 (70.30) |
| (b) Give reasons for non-participation at each stage | 14 (8.48) | 0 (0) | ||
| (c) Consider use of a flow diagram | 25(15.15) | 0 (0) | ||
| Descriptive data | 14 | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | 79 (47.88) | 82 (49.70) |
| (b) Indicate number of participants with missing data for each variable of interest | 14 (8.48) | 0 (0) | ||
| (c) Cohort study—Summarise follow-up time (eg, average and total amount) | 6 (15.79) | 0 (0) | ||
| Outcome data | 15 | Cohort study—Report numbers of outcome events or summary measures over time Case-control study—Report numbers in each exposure category, or summary measures of exposure Cross-sectional study—Report numbers of outcome events or summary measures | 163 (98.79) | 0 (0) |
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included | 58 (35.16) | 68 (41.21) |
| (b) Report category boundaries when continuous variables were categorized | 26 (15.76) | 0 (0) | ||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | 0 (0) | 0 (0) | ||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | 20 (12.12) | 0 (0) |
| Key results | 18 | Summarise key results with reference to study objectives | 165 (100) | 0 (0) |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 87 (52.73) | 16 (9. 69) |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 137 (83.03) | 18 (10.91) |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 45 (27.27) | 2 (1.21) |
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 20 (12.12) | 0 (0) |
Note:The compliance of 6b refer to the compliance of match studies (n = 56, 73.21 = 41/58*100%). The compliance of 14c refer to the compliance of cohort studies (n = 38, 15.79% = 6/38*100%)
“Reported” and “partly reported” was combined as adherence
Fig. 2The compliance of three study types in each item
The main characteristics of included studies
| Characteristic | N (%) | Mean (SD) | ||
|---|---|---|---|---|
| Type of study | ||||
| Cohort studies | 38 (23.03) | 15.58 ± 1.70* | ||
| Case-control studies | 66 (40.00) | 13.77 ± 1.56 | 14.53 | < 0.001 |
| Cross-sectional studies | 61 (36.97) | 14.05 ± 1.86 | ||
| Funding support | ||||
| No | 143 (87.27) | 14.15 ± 1.79 | −2.41 | 0.017 |
| Yes | 21 (12.73) | 15.17 ± 2.01 | ||
| Number of published papers during postgraduate period | ||||
| < 2 | 60 (36.36) | 13.86 ± 1. 67 | −2.37 | 0.019 |
| ≥ 2 | 105 (63.64) | 14.56 ± 1.90 | ||
| Number of the statistical methods | ||||
| < 3 | 73 (44.24) | 13.80 ± 1.77 | −3.12 | 0.012 |
| ≥ 3 | 92 (55.76) | 14.68 ± 1.81 | ||
| Year of published | ||||
| 2014 | 33 (20) | 14.29 ± 1.83 | ||
| 2015 | 48 (29.10) | 13.80 ± 1.89 | ||
| 2016 | 47 (28.48) | 14.31 ± 1.61 | 2.57 | 0.040 |
| 2017 | 31 (18.79) | 14.71 ± 1.89 | ||
| 2018 | 6 (3.64) | 15.94 ± 1.84* | ||
Note:*P < 0.05compared with other groups
Univariate and Multivariate Logistic Regression Analyses of Predictive Factors Associated With Superior Reporting Quality
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Variables | OR (95%CI) | Adjusted OR (95%CI) | ||
| Type | ||||
| Cross-sectional studies | 1 | |||
| Case-control studies | 0.73 (0.29–1.84) | 0.502 | 0.66 (0.25–1.77) | 0.410 |
| Cohort studies | 4.08 (1. 67–10.00) | 0.002 | 3.41 (1.27–9.16) | 0.015 |
| Funding support | ||||
| No | 1 | |||
| Yes | 2.71 (1.05–7.02) | 0.040 | 4.37 (3.52–7.48) | < 0.001 |
| Number of published papers during postgraduate period | ||||
| < 2 | 1 | |||
| ≥ 2 | 2.52 (1.11–5.73) | 0.028 | 3.46 (1.40–8.60) | 0.007 |
| Number of the statistical methods | ||||
| < 3 | 1 | |||
| ≥ 3 | 3.33 (1.46–7.56) | 0.004 | 1.893 (0.74–4.74) | 0.183 |
| Year | 1.32 (0.96–1.82) | 0.088 | ||
Note: The included articles were divided into superior and inferior reporting quality groups according to the cut-off value (the 75 percentile of the STROBE score, 15.40)